Goldman Sachs upgrades Palantir (PLTR.US) to "Buy" with a target price of $230, optimistic about AI growth continuing until 2027.
智通财经2026/10/09 00:46According to Zhitong Finance APP, Goldman Sachs has upgraded the rating of enterprise software company Palantir (PLTR.US) from "Neutral" to "Buy", citing the company's recent underperformance in stock price and increased valuation appeal.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Coreweave discusses data center cooperation with South Korea
According to ZDNet, Coreweave (CRWV.US) is in discussions with South Korea regarding cooperation on data centers.
Sberbank of Russia reported a net profit of 168.5 billions rubles in September
Sberbank of Russia announced that, according to Russian accounting standards, its net profit for September was 168.5 billion rubles.
The yield on France's 10-year government bond dropped by 8 basis points to 4.82%.
France leads the eurozone bond market, with the 10-year government bond yield falling by 8 basis points to 4.82%.
Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium; IPO price falls to lower range at $14.
According to Zhitong Finance APP, TRex Bio Inc., an early-stage biotechnology company focused on autoimmune and inflammatory diseases, raised 116.7 million dollars through its IPO, pricing at the lower end of its indicated range.
Crypto prices
More
